Processes for production and purificatio of normal propyl bromide

Details for Australian Patent Application No. 2006236815 (hide)

Owner Albemarle Corporation

Inventors Hall, Tyson J.; McKinnie, Bonnie G.; Dadgar, Alireza M.; Harrod, William B.

Agent Davies Collison Cave

Pub. Number AU-A-2006236815

PCT Pub. Number WO2006/113307

Priority 60/673,391 18.04.05 US

Filing date 13 April 2006

Wipo publication date 26 October 2006

International Classifications

C07C 19/075 (2006.01) Acyclic saturated compounds containing halogen atoms

C07C 17/08 (2006.01) Compounds containing carbon and halogens with or without hydrogen

C07C 17/383 (2006.01) Compounds containing carbon and halogens with or without hydrogen

Event Publications

1 November 2007 PCT application entered the National Phase

  PCT publication WO2006/113307 Priority application(s): WO2006/113307

22 May 2008 Amendment Made

  The nature of the amendment is: Amend the invention title to read 2006247065 Amicus Therapeutics Inc. The nature of the amendment is: Amend the name of the inventor to read Boyd, Robert; Lee, Gary; Sheth, Kamlesh; Zhu, Xiaoxiang and Mugrage, Benjamin

1 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006236816-Method for treating inflammatory bowel disease (IBD) by an anti-CD20 antibody

2006236812-Combinations, methods and compositions for treating cancer